Approval · Notice of Compliance 12451 · 2011
IMPROVEST: Notice of Compliance 12451
Issued June 22, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12451
- Date
- June 22, 2011
- Company
- Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Immunological
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMPROVEST | 02369532 | Marketed |
Medicinal ingredients
- GONADOTROPIN RELEASING FACTOR ANALOG-PROTEIN CONJUGATE 0.2 MG per ML